The Directory of Pharma Companies and News

Johnson & Johnson

At the Janssen Pharmaceutical Companies of Johnson & Johnson, we are working to create a world without disease. Transforming lives by finding new and better ways to prevent, intercept, treat and cure disease inspires us. We bring together the best minds and pursue the most promising science. We are Janssen. We collaborate with the world for the health of everyone in it.
Category: Pharmaco
Category: Pharmaco

Johnson & Johnson News

2016-07-18Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2016
2016-05-17Johnson & Johnson Announces Collaboration with HP Inc. Subsidiary to Create Personalized Health Care Solutions with 3D P...
2016-05-09Johnson & Johnson to Participate in the 2016 UBS Global Healthcare Conference
2016-04-28Johnson & Johnson Announces Dividend Increase of 6.7%
2016-04-27Johnson & Johnson Consumer Inc. to Acquire NeoStrata Company, Inc., a Leader in Dermocosmetics
2016-04-19Global Public-Private Partnership Announces Publication of Positive Phase 1 Data for Ebola Vaccine Regimen in JAMA
2016-04-19Johnson & Johnson Reports 2016 First-Quarter Results
2016-03-16Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium
2016-03-03Johnson & Johnson to Participate in Barclays Global Healthcare Conference
2016-02-09Johnson & Johnson to Participate in RBC Capital Markets Global Healthcare Conference
2016-02-08RHINOCORT® Allergy Spray Now Available Over The Counter Nationally
2016-01-26Johnson & Johnson Reports 2015 Fourth-Quarter Results
2016-01-20Johnson & Johnson Joins First Industry-wide Call for New Collective Action to Address Antimicrobial Resistance
2016-01-19Johnson & Johnson Announces Actions to Strengthen Medical Devices Leadership Position in Evolving Healthcare Marketplace
2016-01-08Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. Announce Agreement with Chia Tai Tianqing Pharmaceutical ...
2016-01-06Johnson & Johnson Health and Wellness Solutions Teams with Plug and Play to Launch Health and Wellness Technology Accele...
2016-01-06Johnson & Johnson Partners with Leading Universities to Advance Women’s Education in Science, Technology, Engineering, M...
2016-01-04Johnson & Johnson Announces Quarterly Dividend for First Quarter 2016
2015-12-28Johnson & Johnson to Participate in the 34th Annual JP Morgan Health Care Conference
2015-12-22Johnson & Johnson to Host Fourth-Quarter/Full-Year 2015 Investor Conference Call on Results
2015-12-09Johnson & Johnson Announces Formation of Verb Surgical Inc., In Collaboration With Verily
2015-12-07Johnson & Johnson Announces Completion Of Novira Therapeutics, Inc. Acquisition
2015-12-01Johnson & Johnson Marks World AIDS Day with Major New Global Commitments to End HIV Infection in Adolescent Girls and Wo...
2015-11-20Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc.
2015-11-20Janssen Submits INVOKAMET® XR (Canagliflozin / Metformin Hydrochloride Extended Release) for Approval by the U.S. FDA as...
2015-11-06Important Global Data from XARELTO® EXPLORER Cardiovascular Research Program Highlighted in 17 Presentations at the Amer...
2015-11-04Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc.
2015-10-28Johnson & Johnson to Participate in the 24th Annual Credit Suisse Health Care Conference
2015-10-22Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2015
2015-10-13Johnson & Johnson Reports 2015 Third-Quarter Results:
2015-10-13Johnson & Johnson Announces $10 Billion Share Repurchase Program
2015-10-09Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
2015-10-05Johnson & Johnson Announces Completion of Cordis Divestiture to Cardinal Health
2015-09-25Janssen’s daratumumab accepted for accelerated CHMP assessment for treatment of European patients with heavily pre-treat...
2015-09-16Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
2015-09-15Janssen Initiates FIRST, a Novel Study to Evaluate the Benefit of Caregiver Education in Improvement of Outcomes for Pat...
2015-09-08Your Story, Your HIV Wisdom™ Brings Together HIV Voices and Supports HIV Community Organizations
2015-09-04U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma
2015-09-03Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference
2015-09-01New Global Real-World Data from Atrial Fibrillation Studies Confirm the Safety Profile of XARELTO®
2015-08-28Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference
2015-08-04CELLSEARCH® System Recognized as Landmark Innovation in Cancer Research
2015-07-20Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2015
2015-07-14Johnson & Johnson Reports 2015 Second-Quarter Results
2015-07-09Johnson & Johnson Health and Wellness Solutions Announces New Mobile Health Assessment
2015-07-09Phase 2B Findings Published In The New England Journal Of Medicine Demonstrate Significant Efficacy Of Guselkumab In Tre...
2015-07-08CELLSEARCH® System chosen as platform for new research on PD-L1 and Circulating Tumor Cells
2015-07-06Daratumumab Expanded Access Program Open to Eligible U.S. Patients with Heavily Pre-Treated Multiple Myeloma
2015-07-01Investigational HIV Vaccine Regimen Shows Encouraging Results in Non-Human Primates
2015-06-29STELARA® Receives European Commission Approval For Treatment Of Adolescents With Moderate-To-Severe Psoriasis In Europe
2015-06-26SIMPONI® Receives European Commission Approval For Treatment Of Non-Radiographic Axial Spondyloarthritis
2015-06-25INVEGA TRINZA™, First and Only Four-Times-A-Year Treatment for Schizophrenia, Now Commercially Available
2015-06-25Johnson & Johnson Consumer Companies, Inc. Collaborates with Walgreens to Improve Health Outcomes
2015-06-18Depuy Synthes Companies Announces Five-Year Cooperation Agreement With The AO Foundation
2015-06-16Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
2015-06-09CEO and Director of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board of Directors
2015-06-05Janssen Initiates Rolling Submission of Biologic License Application (BLA) for daratumumab with U.S. FDA for the Treatme...
2015-06-02Data at EULAR 2015 Showcase Commitment of Janssen to Advancing Innovative Treatments for Immune and Inflammatory Disease...
2015-06-01Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma
2015-05-30Ibrutinib (IMBRUVICA®) HELIOS Interim Analysis Study Data Show Significant Reductions in Risk of Progression or Death in...
2015-05-30Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Hea...
2015-05-28Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis
2015-05-28New Clinical Research Program Initiated for the Prevention and Treatment of Life-Threatening Blood Clots in Patients wit...
2015-05-22STELARA® Receives CHMP Positive Opinion For Treatment Of Adolescents With Moderate To Severe Psoriasis In Europe
2015-05-22SIMPONI® Receives CHMP Positive Opinion For Treatment Of Non-Radiographic Axial Spondyloarthritis In Europe
2015-05-22Janssen Receives Positive CHMP Opinion Recommending IMBRUVICA® (ibrutinib) for the Treatment of Waldenström’s Macroglobu...
2015-05-20Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New P...
2015-05-19New Real-World Data Show Adults with Type 2 Diabetes, Including Those Taking Multiple Diabetes Medications, Achieve Bloo...
2015-05-15Real-World Data Presented at American Geriatrics Society Meeting Show Consistent Safety of XARELTO® in Elderly Patients
2015-05-14New Data on XARELTO® Versus Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing Catheter Ablation Presented...
2015-05-12U.S. FDA Issues Complete Response Letter to sNDA Seeking to Expand the Label for INVEGA SUSTENNA®
2015-05-11MOTRIN® Make It Happen Weekends Program Celebrates and Inspires Unstoppable Women This Spring
2015-05-11Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Med...
2015-05-04Johnson & Johnson Announces Revival of Kilmer Conference — The Premier Global Forum for Sterility Assurance
2015-04-30Johnson & Johnson to Participate in the 2015 Deutsche Bank 40th Annual Health Care Conference
2015-04-29Johnson & Johnson Announces Further Patent and Trademark Office Action Related to REMICADE®
2015-04-23Johnson & Johnson Announces Dividend Increase of 7.1%
2015-04-20Johnson & Johnson to Host Pharmaceutical Business Review
2015-04-14Johnson & Johnson and IBM Announce Plans to Collaborate on Advanced Solutions Designed to Transform Healthcare Delivery
2015-04-13Johnson & Johnson Reports 2015 First-Quarter Results:
2015-04-08Janssen Highlights Hepatitis C Virus Development Program at The International Liver Congress™ 2015 of the European Assoc...
2015-04-02Ethicon’s HARMONIC FOCUS®+ Shears Now Proven To Produce Vessel Seal Strength Equivalent To Advanced Bipolar Devices
2015-03-31New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in...
2015-03-30New Study Shows Reduced Hospital Admissions and Costs for Deep Vein Thrombosis Patients Treated with XARELTO® Compared t...
2015-03-27Johnson & Johnson Announces Definitive Agreement To Collaborate With Google To Advance Surgical Robotics
2015-03-27Johnson & Johnson to Webcast Annual Meeting of Shareholders
2015-03-18Janssen Acquires XO1 Limited
2015-03-18The Makers Of ZYRTEC® Partner With Gilt City To Address The Beauty And Fashion Challenges Of Allergy Season
2015-03-17Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
2015-03-16Phase 3 Study with IMBRUVICA® (ibrutinib) Combination Demonstrates Significant Delay in Disease Progression
2015-03-16Johnson & Johnson Announces Strategic Investment Alliance to Combat Dementia Globally
2015-03-10McNeil Consumer Healthcare Resolves U.S. Department of Justice Investigation
2015-03-02Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis
2015-02-26Johnson & Johnson Announces Formation of New Health and Wellness Platform Designed to Transform Health Care Delivery and...
2015-02-12Johnson & Johnson Announces Patent and Trademark Office Action Related to REMICADE®
2015-02-11Janssen Launches Three New Research Platforms Focused on Redefining Healthcare
2015-02-11Janssen Sets A Course To Intercept Type 1 Diabetes Together With JDRF
2015-02-10Depuy Synthes Companies Acquires Olive Medical Corporation
Brought to you by - Latest Jobs in Pharma
Brought to you by - Latest Jobs in Pharma.